$4.10
0.9128.53%
At Close: -
$4.00
-0.1-2.44%
After Hours: 4:53 PM EDT
15 minutes delayed
Relmada Therapeutics
RLMDNASDAQ
Relmada Therapeutics (RLMD) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestRelmada Therapeutics (NASDAQ:RLMD) Stock Quotes, Forecast and News Summary
Relmada Therapeutics Stock (NASDAQ: RLMD) stock price, news, charts, stock research, profile.
| Open | $3.19 |
| Close | $4.10 |
| Volume / Avg. | 418.00K / 92.78K |
| Day Range | 3.18 - 4.12 |
| 52 Wk Range | 2.42 - 7.22 |
| Market Cap | $120.70M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 80 |
| Short Interest | 5.24% |
| Days to Cover | 13.76 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Relmada Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chem...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Relmada Therapeutics (RLMD) stock?
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Who are Relmada Therapeutics (RLMD) competitors?
Other companies in Relmada Therapeutics’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Nutriband (NASDAQ:NTRB).
What is the target price for Relmada Therapeutics (RLMD) stock?
There is no analysis for Relmada Therapeutics.
What is the forecast for Relmada Therapeutics (RLMD) stock?
Relmada Therapeutics has a consensus price target of $15.17.
Current stock price for Relmada Therapeutics (RLMD)?
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $4 last updated Today at July 9, 2024 at 4:53 PM EDT.
Does Relmada Therapeutics (RLMD) pay a dividend?
There are no upcoming dividends for Relmada Therapeutics.
When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?
Relmada Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Relmada Therapeutics (RLMD) going to split?
There is no upcoming split for Relmada Therapeutics.
What sector and industry does Relmada Therapeutics (RLMD) operate in?
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.